Global air fluidized therapy bed sales are expected to reach USD 653.5 million in 2023, forecast to grow at a CAGR of 5.7% to be valued at USD 1,135 million from 2023 to 2033. Air fluidized therapy beds have shown an overall growth of a 4.1% CAGR from 2018 to 2022.
Due to the increasing number of accidents and injuries, it has become an important priority for medical centers to provide comfortable and safe resting areas for their patients, which is why demand for air fluidized therapy beds is growing in the market. The technology used in the beds and their comfort are the factors that help beds thrive in an increasingly competitive market.
A growing need for advanced and cutting-edge healthcare products has contributed to the growth of air fluidized therapy beds worldwide. To treat patients with utmost comfort, hospitals and home care providers are placing significant trust in these beds.
Using air fluidized bed therapy is a beneficial way for those who have wounds, ulcers, and other illnesses, and those who are also suffering from intense pain to be relieved. These beds are also used by patients who are suffering from air fluidized bed therapy. A fluidized air bed therapy is mainly used for the treatment of wounds and other skin-related health conditions. As a result, the players are delivering the beds based on the indications.
To treat the skin, air fluidized beds are specially designed to provide a therapeutic level of moisture and other conditions based on the patient's needs. By reducing the pressure and sharing inside the bed, the airflow inside the bed promotes better sleep for all the body parts. In addition to pressure dynamic and temperature controllers, a variety of sensors are being developed for the comfort of patients.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
With the growing number of diseases, hospitals must provide better conditions for patients to recover. Air fluidized therapy beds are a great solution for this requirement since they provide suitable air circulation and treatment for patients in medical facilities. As a clinical benefit, AFT reduces the number of hospitalizations and emergency room visits for patients with pressure ulcers who are in long-term care facilities.
In addition, these beds decrease mortality rates among patients who have extensive burns and inhalation injuries and promote rapid healing and greater comfort among patients with burn injuries. As medical centers place utmost emphasis on patient comfort, air fluidized therapy beds are likely to gain great popularity shortly.
They reduce friction, shear, and pressure on the patient, so they get a better chance of recovering faster. Increasing technological innovation and advancement in treatments have made these beds in great demand at hospitals worldwide. Furthermore, for patients with skin-related issues, the demand for less noisy and comfortable beds has helped drive the air fluidized therapy bed market.
AHRQ (Agency for Healthcare Research & Quality) estimates that 2.5 million Americans suffer from pressure ulcers every year. As key companies in the fields prepare battery-operated beds that provide comfort to bedridden patients, the need for comfortable beds has also increased.
| Attributes | Value |
|---|---|
| Air Fluidized Therapy Bed Market Size (2023) | USD 653.5 million |
| Air Fluidized Therapy Bed Market Projected Size (2033) | USD 1,135 million |
| Air Fluidized Therapy Bed Market CAGR (2023 to 2033) | 5.7% |
While air fluidized therapy beds have many benefits for medical treatment, there are also a few factors that hinder their growth in the market. It is contraindicated to use air fluidized beds for patients with unstable spines, as the lack of adequate back support causes prolonged coughing for the patient. This impedes the market growth for these beds in the market.
In addition, patients who suffer from pulmonary secretion diseases or have trouble moving should refrain from using these beds to maintain their better health. Although this is not a constraint, in the long run, it limits the growth of air fluidized therapy beds in the market.
For many patients, air fluidized therapy beds are a better solution than conventional round therapy beds, but, due to their special features, the manufacturing costs associated with these beds are very high. Additionally, the maintenance costs are likely to be too high for the hospital as well as the patients which further hinder the growth of these beds in the market. As a result, the cost of air-fluidized therapy beds restricts their future growth in the market.
Principal Consultant
| Countries | Market Share (2022) |
|---|---|
| United States | 36% |
| Germany | 8.2% |
| Japan | 3.8% |
North America was the leading market for Air Fluidized Therapy Beds market and the trend is expected to continue into the forecast period owing to the increasing disposable incomes, and growing demand for consumer electronics in the region.
The growing demand for Air Fluidized Therapy Beds for safe packaging purposes due to the increase in online shopping applications is expected to augment the Air Fluidized Therapy Beds market. As per the Future Market Insights analysis, the North American region is forecast to have a 35% total share of the Air Fluidized Therapy Beds market.
North America is expected to be the next dominant region witnessing high adoption rates for the Air Fluidized Therapy Beds market during the forecast period. With a high concentration of manufacturing industries in North America, demand for the Air Fluidized Therapy Beds market is anticipated to rise in the region.
Approximately one-third of the patients in North America have diseases that prevent them from moving, therefore the need for comfortable beds is high in this region. The demand for air fluidized therapy beds in this area is high since these beds are one of the best options available to patients suffering from this condition.
According to this report, air fluidized therapy beds hold a market share of 37.8% by 2022. North American manufacturers typically dominate the global air fluidized bed market without much effort, which helps the region dominate the industry worldwide. Furthermore, the ongoing research and development contribute greatly to the growth of these beds.
Patients are turning towards these beds for home use instead of being hospitalized, resulting in significant growth in the air fluidized therapy bed market. Even though they are expensive, these beds are highly effective and reduce the healing time for pressure injuries such as ulcers, which is why they are so popular in these regions. A variety of research is being conducted to update these beds so that patients with spinal issues also benefit from them.
The use of air fluidized therapy beds in Europe is on the rise due to the increasing awareness regarding the different types of therapies for better recuperation of patients at home in this region. The market share of these beds has grown as more hospitals recommend their use in this region. The market share is expected to reach 28.3% in 2022.
With a growing demand for well-equipped facilities and advanced treatments in homes and hospitals, there is a growing demand for these beds in the market. The growing geriatric population and the presence of chronic diseases in these regions have contributed to the growth of the air fluidized therapy bed market in these regions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market has a 5.7% growth potential through 2033.
The global air fluidized therapy bed market size to reach USD 1,135 million by 2033.
The global air fluidized therapy bed market advanced at a 4.1% HCAGR from 2018 to 2022.
The market is valued at USD 653.5 million in 2023.
The estimated market share for the North American region is 35%.
From 2023 to 2033, the market share is anticipated to surpass 28.3%.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 5.1. Pressure Ulcers 5.2. Burns 5.3. Other Indications 6. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Hospitals 6.2. Ambulatory Surgical Centers 6.3. Other End Users 7. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Western Europe 7.4. Eastern Europe 7.5. South Asia and Pacific 7.6. East Asia 7.7. Middle East and Africa 8. North America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Western Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Eastern Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia and Pacific Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East and Africa Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Hill-Rom 17.2. Dolphin System 17.3. AURORA MFG 17.4. American Medical Equipment 17.5. Blue Chip Medical 17.6. Akthel Healthcare BV 17.7. ArjoHuntleigh 17.8. Envella 17.9. Kinetic Concepts 17.10. Denghuang Medical 17.11. Redactron International BV 17.12. Shandong Hesheng Medical Equipment Co., Ltd. 18. Assumptions & Acronyms Used 19. Research Methodology
Healthcare
October 2024
REP-GB-6348
223 pages
Explore Healthcare Insights
View Reports
Air Fluidized Therapy Beds Market
